Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q3 2015 (← Previous) (Next →)

Filing Date: Nov 16, 2015

Total Value: $222M (100.0% shares, 0.0% debt)

Holdings (74)

— Allergan PLC 4.6%
Value $10.19M Shares 37,500 Share Price $271.81 Est. Cost/Share $303.47 Unrealized @ Report Date —
— NUVASIVE INC 3.8%
Value $8.439M Shares 175,000 Share Price $48.22 Est. Cost/Share $44.27 Unrealized @ Report Date —
— FIVE PRIME THERAPEUTICS INC 3.5%
Value $7.695M Shares 500,000 Share Price $15.39 Est. Cost/Share $23.02 Unrealized @ Report Date —
— MALLINCKRODT PUB LTD CO 3.5%
Value $7.673M Shares 120,000 Share Price $63.94 Est. Cost/Share $63.94 Unrealized @ Report Date —
— ZELTIQ AESTHETICS INC 3.4%
Value $7.527M Shares 235,000 Share Price $32.03 Est. Cost/Share $27.54 Unrealized @ Report Date —
— NANOSTRING TECHNOLOGIES INC 3.2%
Value $7.2M Shares 450,000 Share Price $16.00 Est. Cost/Share $13.25 Unrealized @ Report Date —
AMGN AMGEN INC 3.1%
Value $6.916M Shares 50,000 Share Price $138.32 * Est. Cost/Share $116.24 Unrealized @ Report Date 0.0%
GILD GILEAD SCIENCES INC 3.1%
Value $6.873M Shares 70,000 Share Price $98.19 * Est. Cost/Share $77.50 Unrealized @ Report Date 0.0%
— CELGENE CORP 2.9%
Value $6.49M Shares 60,000 Share Price $108.17 Est. Cost/Share $108.17 Unrealized @ Report Date —
— ALNYLAM PHARMACEUTICALS INC 2.7%
Value $6.027M Shares 75,000 Share Price $80.36 Est. Cost/Share — Unrealized @ Report Date —
— BRISTOL MYERS SQUIBB CO 2.7%
Value $5.92M Shares 100,000 Share Price $59.20 Est. Cost/Share — Unrealized @ Report Date —
— FLAMEL TECHNOLOGIES SA 2.6%
Value $5.709M Shares 350,000 Share Price $16.31 Est. Cost/Share $19.78 Unrealized @ Report Date —
EW EDWARDS LIFESCIENCES CORP 2.6%
Value $5.687M Shares 40,000 Share Price $142.18 * Est. Cost/Share $24.14 Unrealized @ Report Date 0.0%
— HORIZON PHARMA PLC 2.5%
Value $5.451M Shares 275,000 Share Price $19.82 Est. Cost/Share $30.67 Unrealized @ Report Date —
CYH COMMUNITY HEALTH SYS INC NEW 2.3%
Value $5.132M Shares 120,000 Share Price $42.77 * Est. Cost/Share $45.85 Unrealized @ Report Date 0.0%
— ZOGENIX INC 2.2%
Value $4.995M Shares 370,000 Share Price $13.50 Est. Cost/Share $13.50 Unrealized @ Report Date —
— HEARTWARE INTL INC 2.1%
Value $4.708M Shares 90,000 Share Price $52.31 Est. Cost/Share $52.31 Unrealized @ Report Date —
IART INTEGRA LIFESCIENCES HOLDINGS CORP 2.0%
Value $4.466M Shares 75,000 Share Price $59.55 * Est. Cost/Share $31.27 Unrealized @ Report Date 0.0%
— ALCOBRA LTD 1.9%
Value $4.161M Shares 688,961 Share Price $6.04 Est. Cost/Share $5.68 Unrealized @ Report Date —
— GENMARK DIAGNOSTICS INC 1.9%
Value $4.132M Shares 525,000 Share Price $7.87 Est. Cost/Share $9.06 Unrealized @ Report Date —
— DYNAVAX TECHNOLOGIES CORP 1.8%
Value $4.049M Shares 165,000 Share Price $24.54 Est. Cost/Share $24.54 Unrealized @ Report Date —
HCA HCA HOLDINGS INC 1.7%
Value $3.868M Shares 50,000 Share Price $77.36 * Est. Cost/Share $82.31 Unrealized @ Report Date 0.0%
— AEGERION PHARMACEUTICALS INC 1.5%
Value $3.4M Shares 250,000 Share Price $13.60 Est. Cost/Share $13.60 Unrealized @ Report Date —
PCRX PACIRA PHARMACEUTICALS INC 1.5%
Value $3.288M Shares 80,000 Share Price $41.10 * Est. Cost/Share $61.25 Unrealized @ Report Date 0.0%
ISRG INTUITIVE SURGICAL INC 1.4%
Value $3.217M Shares 7,000 Share Price $459.57 * Est. Cost/Share $55.94 Unrealized @ Report Date +1.3%
— SYNERGY PHARMACEUTICALS INC 1.4%
Value $3.18M Shares 600,000 Share Price $5.30 Est. Cost/Share $5.30 Unrealized @ Report Date —
— ATARA BIOTHERAPEUTICS INC 1.4%
Value $3.144M Shares 100,000 Share Price $31.44 Est. Cost/Share $52.76 Unrealized @ Report Date —
QURE UNIQURE B.V. 1.4%
Value $3.068M Shares 150,000 Share Price $20.45 * Est. Cost/Share $28.48 Unrealized @ Report Date -7.5%
— SPECTRANETICS CORP 1.3%
Value $2.948M Shares 250,000 Share Price $11.79 Est. Cost/Share $11.79 Unrealized @ Report Date —
— THERAPEUTICSMD INC 1.3%
Value $2.93M Shares 500,000 Share Price $5.86 Est. Cost/Share — Unrealized @ Report Date —
— BELLICUM PHARMACEUTICALS INC 1.3%
Value $2.906M Shares 200,000 Share Price $14.53 Est. Cost/Share $14.53 Unrealized @ Report Date —
— CYNAPSUS THERAPEUTICS INC 1.3%
Value $2.83M Shares 175,000 Share Price $16.17 Est. Cost/Share $16.29 Unrealized @ Report Date —
INCY INCYTE CORP 1.2%
Value $2.758M Shares 25,000 Share Price $110.32 Est. Cost/Share $112.12 Unrealized @ Report Date 0.0%
— VITAE PHARMACEUTICALS INC 1.2%
Value $2.753M Shares 250,000 Share Price $11.01 Est. Cost/Share $11.71 Unrealized @ Report Date —
— GW PHARMACEUTICALS PLC 1.2%
Value $2.741M Shares 30,000 Share Price $91.37 Est. Cost/Share $103.82 Unrealized @ Report Date —
— ACORDA THERAPEUTICS INC 1.2%
Value $2.651M Shares 100,000 Share Price $26.51 Est. Cost/Share $26.51 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS INC 1.2%
Value $2.565M Shares 225,000 Share Price $11.40 * Est. Cost/Share $12.95 Unrealized @ Report Date +3.1%
— HERON THERAPEUTICS INC 1.1%
Value $2.44M Shares 100,000 Share Price $24.40 Est. Cost/Share — Unrealized @ Report Date —
— RELYPSA INC 1.0%
Value $2.221M Shares 120,000 Share Price $18.51 Est. Cost/Share $18.51 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 1.0%
Value $2.188M Shares 55,000 Share Price $39.78 * Est. Cost/Share $42.40 Unrealized @ Report Date +14.0%
— TONIX PHARMACEUTICALS HOLDIN 0.9%
Value $2.107M Shares 398,300 Share Price $5.29 Est. Cost/Share $7.16 Unrealized @ Report Date —
— ZAFGEN INC 0.9%
Value $2.077M Shares 65,000 Share Price $31.95 Est. Cost/Share $31.95 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS 0.9%
Value $2.073M Shares 300,000 Share Price $6.91 Est. Cost/Share $6.91 Unrealized @ Report Date —
— NEURODERM LTD 0.9%
Value $2.067M Shares 100,000 Share Price $20.67 Est. Cost/Share $20.67 Unrealized @ Report Date —
— PTC THERAPEUTICS INC 0.9%
Value $2.003M Shares 75,000 Share Price $26.71 Est. Cost/Share — Unrealized @ Report Date —
CLLS CELLECTIS - ADR 0.9%
Value $1.977M Shares 75,000 Share Price $26.36 Est. Cost/Share $36.08 Unrealized @ Report Date —
— EPIZYME INC 0.9%
Value $1.929M Shares 150,000 Share Price $12.86 Est. Cost/Share $21.60 Unrealized @ Report Date —
— LION BIOTECHNOLOGIES INC 0.8%
Value $1.728M Shares 300,000 Share Price $5.76 Est. Cost/Share $10.85 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 0.8%
Value $1.727M Shares 40,800 Share Price $42.33 Est. Cost/Share $50.23 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A/S - ADR 0.8%
Value $1.719M Shares 97,135 Share Price $17.70 Est. Cost/Share $17.69 Unrealized @ Report Date —
— GENOCEA BIOSCIENCES INC 0.7%
Value $1.507M Shares 220,000 Share Price $6.85 Est. Cost/Share $11.86 Unrealized @ Report Date —
— DERMA SCIENCES INC 0.6%
Value $1.413M Shares 300,000 Share Price $4.71 Est. Cost/Share $4.71 Unrealized @ Report Date —
ACHC ACADIA PHARMACEUTICALS 0.6%
Value $1.323M Shares 40,000 Share Price $33.08 * Est. Cost/Share $76.93 Unrealized @ Report Date 0.0%
RGNX REGENXBIO INC 0.6%
Value $1.322M Shares 60,000 Share Price $22.03 * Est. Cost/Share $25.52 Unrealized @ Report Date 0.0%
— CHIASMA INC 0.6%
Value $1.292M Shares 65,000 Share Price $19.88 Est. Cost/Share $19.88 Unrealized @ Report Date —
— CORIUM INTERNATIONAL INC 0.5%
Value $1.169M Shares 125,000 Share Price $9.35 Est. Cost/Share $9.35 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 0.5%
Value $1.1M Shares 150,000 Share Price $7.33 Est. Cost/Share $10.25 Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 0.5%
Value $1.066M Shares 25,000 Share Price $42.64 Est. Cost/Share $27.98 Unrealized @ Report Date —
CPRX CATALYST PHARM PARTNERS INC 0.5%
Value $1.05M Shares 350,000 Share Price $3.00 * Est. Cost/Share $4.32 Unrealized @ Report Date 0.0%
VCYT VERACYTE INC 0.4%
Value $951K Shares 202,800 Share Price $4.69 * Est. Cost/Share $9.65 Unrealized @ Report Date -1.3%
— CYMABAY THERAPEUTICS INC 0.3%
Value $776K Shares 400,000 Share Price $1.94 Est. Cost/Share $1.94 Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTL IN 0.3%
Value $590K Shares 106,200 Share Price $5.56 Est. Cost/Share — Unrealized @ Report Date —
— BIODELIVERY SCIENCES INTERNATIONAL INC 0.3%
Value $556K Shares 100,000 Share Price $5.56 Est. Cost/Share $7.96 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 0.2%
Value $490K Shares 6,500 Share Price $75.38 * Est. Cost/Share $214.23 Unrealized @ Report Date -55.9%
— AKARI THERAPEUTICS PLC 0.2%
Value $488K Shares 20,325 Share Price $24.01 Est. Cost/Share $24.01 Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 0.2%
Value $476K Shares 89,231 Share Price $5.33 * Est. Cost/Share $6.83 Unrealized @ Report Date 0.0%
— SPARK THERAPEUTICS INC 0.2%
Value $417K Shares 10,000 Share Price $41.70 Est. Cost/Share $41.70 Unrealized @ Report Date —
— ZOSANO PHARMA CORP 0.2%
Value $396K Shares 100,000 Share Price $3.96 Est. Cost/Share $3.96 Unrealized @ Report Date —
— OCERA THERAPEUTICS INC 0.2%
Value $395K Shares 125,000 Share Price $3.16 Est. Cost/Share $10.04 Unrealized @ Report Date —
— UNILIFE CORP NEW 0.2%
Value $343K Shares 350,000 Share Price $0.98 Est. Cost/Share $4.01 Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 0.1%
Value $321K Shares 10,000 Share Price $32.10 * Est. Cost/Share $33.93 Unrealized @ Report Date 0.0%
— RAPTOR PHARMACEUTICAL CORP 0.1%
Value $303K Shares 50,000 Share Price $6.06 Est. Cost/Share $6.06 Unrealized @ Report Date —
— BIOLASE INC 0.1%
Value $270K Shares 300,000 Share Price $0.90 Est. Cost/Share $2.41 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.1%
Value $237K Shares 292,939 Share Price $0.81 Est. Cost/Share $2.45 Unrealized @ Report Date —